NEAUVIA references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
Neauvia Stimulate
Neauvia Stimulate is a biodegradable hyaluronic acid filler cross-linked with PEG and enriched with calcium hydroxyapatite, manufactured by Matex Lab in Brindisi, Italy. It is resorbed over time and intended to restore lost volume of the soft tissue. At 26 mg/mL with a medium to high extrusion force, it is placed in the subdermis and over the periosteum. Neauvia's Stimulate line is the only PEG-HA plus CaHA filler on the market, and Stimulate was named Best Injectable Dermal Filler at the AMWC 2024 Awards.
Key Benefits of Neauvia Stimulate
- 26 mg/mL cross-linked hyaluronic acid enriched with calcium hydroxyapatite
- One of the only PEG-HA plus CaHA fillers on the market
- Named Best Injectable Dermal Filler at the AMWC 2024 Awards
- Studied over 24 weeks for correction of mid-face volume deficit
- Medium to high extrusion force, placed in the subdermis and over the periosteum
- No pathological inflammatory reactions detected so far with Neauvia PEG-HA devices
- No cytotoxic activity detected
- Reversible filling
- High resistance to heat and high thermodynamic stability, allowing combined protocols
Indications and Professional Use
Main indications
- Restoration of lost volume of the soft tissue
- Correction of mid-face volume deficit
Professional use
For professional use. Neauvia Stimulate is only to be used by physicians in accordance with local legislation, trained in the injection techniques of hyaluronic acid based fillers, and is not for retail sale or self-administration. It is placed in the subdermis and/or over the periosteum using the 21G or 22G needle or cannula supplied in the box. Its high thermodynamic stability and heat resistance are what allow it to be used within combined protocols alongside energy-based devices, and it is the filler used in Neauvia's Nlift mid-face synergistic protocol.
Treatment areas
- Face
- Mid-face
Patient profile
Suitable for adult patients presenting with age-related volume loss of the soft tissue, particularly mid-face volume deficit, as determined by the treating practitioner following clinical assessment. Facial ageing is a composite three-dimensional process involving bone, soft tissue and skin, in which deep fat atrophies while superficial fat repositions or hypertrophies, so the practitioner selects the grade of filler and the plane of placement according to which layer has changed.
How Neauvia Stimulate Works
Stimulate combines PEGylated hyaluronic acid with a low concentration of calcium hydroxyapatite. A 24-week post-market, observational, prospective, open-label, single-centre study reported that this formulation effectively addresses skin and subcutaneous tissue concerns, in particular the correction of disorders and of mid-face volume deficit, with the data highlighting an efficient mechanical effect of the PEGylated polymeric acid matrix enriched with low-concentration CaHA. Glycine and L-proline are added to the phosphate buffer solution to tune the viscoelastic properties and swelling resistance. The gel is a temporary filling, with a 6 month degradation average time.
Why Order From Allpara
Allpara offers genuine, verified NEAUVIA products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
How does Stimulate differ from Neauvia Intense?
Composition and plane. Stimulate carries 26 mg/mL hyaluronic acid enriched with calcium hydroxyapatite and is placed in the subdermis or over the periosteum. Intense carries 28 mg/mL without CaHA and is placed in the subcutis or over the periosteum. The Stimulate line is the only one in the range to combine PEG-HA with CaHA.
Why does Stimulate contain calcium hydroxyapatite?
A 24-week post-market study of the PEGylated hyaluronic acid matrix enriched with low-concentration CaHA reported an efficient mechanical effect on skin and subcutaneous tissue, in particular for correcting mid-face volume deficit.
Where can clinics buy Neauvia Stimulate?
ALLPARA supplies Neauvia Stimulate to licensed practitioners, clinics and distributors on a B2B account. Wholesale terms, stock position and batch expiry are released to registered professional buyers.
More from Matex Lab S.P.A
Clinic alternatives
Pick up where you left off
Neauvia Stimulate
Neauvia Stimulate is a biodegradable hyaluronic acid filler cross-linked with PEG and enriched with calcium hydroxyapatite, manufactured by Matex Lab in Brindisi, Italy. It is resorbed over time and intended to restore lost volume of the soft tissue. At 26 mg/mL with a medium to high extrusion force, it is placed in the subdermis and over the periosteum. Neauvia's Stimulate line is the only PEG-HA plus CaHA filler on the market, and Stimulate was named Best Injectable Dermal Filler at the AMWC 2024 Awards.
Key Benefits of Neauvia Stimulate
- 26 mg/mL cross-linked hyaluronic acid enriched with calcium hydroxyapatite
- One of the only PEG-HA plus CaHA fillers on the market
- Named Best Injectable Dermal Filler at the AMWC 2024 Awards
- Studied over 24 weeks for correction of mid-face volume deficit
- Medium to high extrusion force, placed in the subdermis and over the periosteum
- No pathological inflammatory reactions detected so far with Neauvia PEG-HA devices
- No cytotoxic activity detected
- Reversible filling
- High resistance to heat and high thermodynamic stability, allowing combined protocols
Indications and Professional Use
Main indications
- Restoration of lost volume of the soft tissue
- Correction of mid-face volume deficit
Professional use
For professional use. Neauvia Stimulate is only to be used by physicians in accordance with local legislation, trained in the injection techniques of hyaluronic acid based fillers, and is not for retail sale or self-administration. It is placed in the subdermis and/or over the periosteum using the 21G or 22G needle or cannula supplied in the box. Its high thermodynamic stability and heat resistance are what allow it to be used within combined protocols alongside energy-based devices, and it is the filler used in Neauvia's Nlift mid-face synergistic protocol.
Treatment areas
- Face
- Mid-face
Patient profile
Suitable for adult patients presenting with age-related volume loss of the soft tissue, particularly mid-face volume deficit, as determined by the treating practitioner following clinical assessment. Facial ageing is a composite three-dimensional process involving bone, soft tissue and skin, in which deep fat atrophies while superficial fat repositions or hypertrophies, so the practitioner selects the grade of filler and the plane of placement according to which layer has changed.
How Neauvia Stimulate Works
Stimulate combines PEGylated hyaluronic acid with a low concentration of calcium hydroxyapatite. A 24-week post-market, observational, prospective, open-label, single-centre study reported that this formulation effectively addresses skin and subcutaneous tissue concerns, in particular the correction of disorders and of mid-face volume deficit, with the data highlighting an efficient mechanical effect of the PEGylated polymeric acid matrix enriched with low-concentration CaHA. Glycine and L-proline are added to the phosphate buffer solution to tune the viscoelastic properties and swelling resistance. The gel is a temporary filling, with a 6 month degradation average time.
Why Order From Allpara
Allpara offers genuine, verified NEAUVIA products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
How does Stimulate differ from Neauvia Intense?
Composition and plane. Stimulate carries 26 mg/mL hyaluronic acid enriched with calcium hydroxyapatite and is placed in the subdermis or over the periosteum. Intense carries 28 mg/mL without CaHA and is placed in the subcutis or over the periosteum. The Stimulate line is the only one in the range to combine PEG-HA with CaHA.
Why does Stimulate contain calcium hydroxyapatite?
A 24-week post-market study of the PEGylated hyaluronic acid matrix enriched with low-concentration CaHA reported an efficient mechanical effect on skin and subcutaneous tissue, in particular for correcting mid-face volume deficit.
Where can clinics buy Neauvia Stimulate?
ALLPARA supplies Neauvia Stimulate to licensed practitioners, clinics and distributors on a B2B account. Wholesale terms, stock position and batch expiry are released to registered professional buyers.